Herbal-To-Rx Switch? Zyflamend To Undergo Study For Cancer Prevention
This article was originally published in The Tan Sheet
Executive Summary
Columbia University is initiating a clinical trial to evaluate whether the herbal supplement Zyflamend inhibits the onset of prostate cancer in certain patients
You may also be interested in...
Natural Products Expo East In Brief
FDA visits the show: FDA says "several" staffers from the Center for Food Safety & Applied Nutrition and Office of Regulatory Affairs attended the Natural Products Expo West Trade Show in Washington, D.C. Oct. 15. An agency spokesperson claims the FDAers were at the meeting "to stay abreast" of industry happenings...
Natural Products Expo East In Brief
FDA visits the show: FDA says "several" staffers from the Center for Food Safety & Applied Nutrition and Office of Regulatory Affairs attended the Natural Products Expo West Trade Show in Washington, D.C. Oct. 15. An agency spokesperson claims the FDAers were at the meeting "to stay abreast" of industry happenings...
PC-SPES research
Herbal mixture "significantly suppressed cell proliferation in colon cancer cell lines" after 72 hours of exposure, Sergio Huerta, UCLA, et al., report in September Cancer Research. In an in vitro study, 11 female mice were given 250 mg/kg/day PC-SPES (Botanic Lab) five times a week for 10 weeks, while 10 mice in placebo group were given .2 mL "vehicle solution." Researchers also report results of in vivo study demonstrating oral PC-SPES-treated mice saw a "significant decrease in polyp number in the medial and distal segments of the small intestines." Huerta et al. conclude the supplement has "potent anticancer effects and results in both cell cycle arrest and apoptosis." UCLA is working with PC-SPES inventor to guarantee future research on herbal blend, which has been plagued by Rx contamination problems (1"The Tan Sheet" Aug. 5, 2002, In Brief)...